These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2684634)

  • 1. Mutants of H-ras that interfere with RAS effector function in Saccharomyces cerevisiae.
    Michaeli T; Field J; Ballester R; O'Neill K; Wigler M
    EMBO J; 1989 Oct; 8(10):3039-44. PubMed ID: 2684634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In yeast, RAS proteins are controlling elements of adenylate cyclase.
    Toda T; Uno I; Ishikawa T; Powers S; Kataoka T; Broek D; Cameron S; Broach J; Matsumoto K; Wigler M
    Cell; 1985 Jan; 40(1):27-36. PubMed ID: 2981630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The S. cerevisiae CDC25 gene product regulates the RAS/adenylate cyclase pathway.
    Broek D; Toda T; Michaeli T; Levin L; Birchmeier C; Zoller M; Powers S; Wigler M
    Cell; 1987 Mar; 48(5):789-99. PubMed ID: 3545497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different kinetic properties of the two mutants, RAS2Ile152 and RAS2Val19, that suppress the CDC25 requirement in RAS/adenylate cyclase pathway in Saccharomyces cerevisiae.
    Créchet JB; Poullet P; Camonis J; Jacquet M; Parmeggiani A
    J Biol Chem; 1990 Jan; 265(3):1563-8. PubMed ID: 2104846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between the Saccharomyces cerevisiae CDC25 gene product and mammalian ras.
    Segal M; Marbach I; Engelberg D; Simchen G; Levitzki A
    J Biol Chem; 1992 Nov; 267(32):22747-51. PubMed ID: 1429624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of yeast adenylate cyclase by wild-type and mutant RAS proteins.
    Broek D; Samiy N; Fasano O; Fujiyama A; Tamanoi F; Northup J; Wigler M
    Cell; 1985 Jul; 41(3):763-9. PubMed ID: 3891097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the adenylyl cyclase gene that block RAS function in Saccharomyces cerevisiae.
    Field J; Xu HP; Michaeli T; Ballester R; Sass P; Wigler M; Colicelli J
    Science; 1990 Jan; 247(4941):464-7. PubMed ID: 2405488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanine nucleotide activation of, and competition between, RAS proteins from Saccharomyces cerevisiae.
    Field J; Broek D; Kataoka T; Wigler M
    Mol Cell Biol; 1987 Jun; 7(6):2128-33. PubMed ID: 3299060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of yeast RAS2 mutants reveals a new region of ras protein involved in the interaction with GTPase-activating proteins.
    Wood DR; Poullet P; Wilson BA; Khalil M; Tanaka K; Cannon JF; Tamanoi F
    J Biol Chem; 1994 Feb; 269(7):5322-7. PubMed ID: 8106517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of posttranslational modifications on the interaction of Ras2 with adenylyl cyclase.
    Kuroda Y; Suzuki N; Kataoka T
    Science; 1993 Jan; 259(5095):683-6. PubMed ID: 8430318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator.
    Martegani E; Vanoni M; Zippel R; Coccetti P; Brambilla R; Ferrari C; Sturani E; Alberghina L
    EMBO J; 1992 Jun; 11(6):2151-7. PubMed ID: 1376246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse CDC25-like product enhances the formation of the active GTP complex of human ras p21 and Saccharomyces cerevisiae RAS2 proteins.
    Jacquet E; Vanoni M; Ferrari C; Alberghina L; Martegani E; Parmeggiani A
    J Biol Chem; 1992 Dec; 267(34):24181-3. PubMed ID: 1447167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the function of the 70-kilodalton cyclase-associated protein (CAP) by using mutants of yeast adenylyl cyclase defective in CAP binding.
    Wang J; Suzuki N; Nishida Y; Kataoka T
    Mol Cell Biol; 1993 Jul; 13(7):4087-97. PubMed ID: 8391632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant yeast and mammalian RAS mutants that interfere with the CDC25-dependent activation of wild-type RAS in Saccharomyces cerevisiae.
    Powers S; O'Neill K; Wigler M
    Mol Cell Biol; 1989 Feb; 9(2):390-5. PubMed ID: 2651897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro reconstitution of cdc25 regulated S. cerevisiae adenylyl cyclase and its kinetic properties.
    Engelberg D; Simchen G; Levitzki A
    EMBO J; 1990 Mar; 9(3):641-51. PubMed ID: 2155776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel, activated RAS mutations alter protein-protein interactions.
    Dalley BK; Cannon JF
    Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dominant activating mutation in the effector region of RAS abolishes IRA2 sensitivity.
    Tanaka K; Wood DR; Lin BK; Khalil M; Tamanoi F; Cannon JF
    Mol Cell Biol; 1992 Feb; 12(2):631-7. PubMed ID: 1732735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of Saccharomyces cerevisiae Ras for completion of mitosis.
    Morishita T; Mitsuzawa H; Nakafuku M; Nakamura S; Hattori S; Anraku Y
    Science; 1995 Nov; 270(5239):1213-5. PubMed ID: 7502049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic alteration of the distal switch II region of RAS blocks CDC25-dependent signaling functions.
    Mirisola MG; Seidita G; Verrotti AC; Di Blasi F; Fasano O
    J Biol Chem; 1994 Jun; 269(22):15740-8. PubMed ID: 8195227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two types of RAS mutants that dominantly interfere with activators of RAS.
    Jung V; Wei W; Ballester R; Camonis J; Mi S; Van Aelst L; Wigler M; Broek D
    Mol Cell Biol; 1994 Jun; 14(6):3707-18. PubMed ID: 8196614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.